| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,907 | 15,353 | 15,309 | 15,061 | | Cost of Revenue | 4,901 | 3,876 | 4,030 | 4,585 | | | Gross Profit | 12,006 | 11,477 | 11,279 | 10,476 | | | Operating Expenses | | Research Development | 2,689 | 2,543 | 2,271 | 2,089 | | Selling General and Administrative | 6,086 | 3,930 | 4,924 | 4,184 | | Non Recurring | 2,632 | 339 |
-
| (46) | | Others | 755 | 546 | 548 | 576 | | | | Total Operating Expenses | 12,162 | 7,358 |
-
| 6,803 | | | | Operating Income or Loss | (156) | 4,119 | 3,536 | 3,673 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24 | (2,884) | 89 | (944) | | Earnings Before Interest And Taxes | (132) | 1,235 | 3,625 | 2,729 | | Interest Expense | 775 | 768 | 761 | 756 | | Income Before Tax | (907) | 467 | 2,864 | 1,973 | | Income Tax Expense | 29 | 21 | 22 | 55 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (936) | 446 | 2,842 | 1,918 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (936) | 446 | 2,842 | 1,918 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($936) | $446 | $2,842 | $1,918 |
|
0.51% Nasdaq 
Income Statement
